Literature DB >> 3894169

Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease.

U Volta, M Lenzi, R Lazzari, F Cassani, A Collina, F B Bianchi, E Pisi.   

Abstract

Antibodies to gliadin have been detected by immunofluorescence (IFL-AGA) and a micro-ELISA method (ELISA-AGA) in 45 out of 47 (96%) sera from patients with active childhood and adult coeliac disease. The two methods were more sensitive than R1-reticulin antibodies (R1-ARA) which were found only in 28 of the same patients (60%). R1-ARA were always negative in the 26 sera from patients with childhood coeliac disease and adult coeliac disease after gluten free diet, while IFL- and ELISA-AGA were respectively found in three (12%) and in four (15%) out of these patients. Moreover, while R1-ARA and IFL-AGA were strictly confined to coeliac disease. ELISA-AGA were occasionally found in patients with control diseases. These 'false positive' antibodies were all of IgG class and had low titres. In our experience IFL- and ELISA-AGA of IgA class were strictly confined to active childhood coeliac disease and adult coeliac disease. The detection of AGA is useful in monitoring the diet and in the follow up of coeliac disease. IFL- and ELISA-AGA, then, are to be preferred to R1-ARA for the screening of coeliac patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894169      PMCID: PMC1432992          DOI: 10.1136/gut.26.7.667

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  IgA class reticulin antibodies in relatives of patients with coeliac disease.

Authors:  E G Mallas; N Williamson; B T Cooper; W T Cooke
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

2.  IgA and IgG reticulin antibodies in coeliac and non-coeliac patients.

Authors:  O E Eade; R S Lloyd; C Lang; R Wright
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

3.  Antireticulin antibody: incidence and diagnostic significance.

Authors:  P P Seah; L Fry; E J Holborow; M A Rossiter; W F Doe; A F Magalhaes; A V Hoffbrand
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

4.  Types of 'reticulin' antibodies detected in human sera by immunofluorescence.

Authors:  M Rizzetto; D Doniach
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

5.  Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease, and their relation to immunoglobulins and dietary antibodies.

Authors:  M H Alp; R Wright
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

6.  Antibodies to gluten and reticulin in gastrointestinal diseases.

Authors:  K P Eterman; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

7.  Antireticulin antibodies in dermatitis herpetiformis and adult coeliac disease. Their relationship to a gluten free diet and jejunal histology.

Authors:  M Lancaster-Smith; P Kumar; M L Clark; R Marks; G D Johnson
Journal:  Br J Dermatol       Date:  1975-01       Impact factor: 9.302

8.  Binding of wheat gliadin in vitro to reticulum in normal and dermatitis herpetiformis skin.

Authors:  D J Unsworth; G D Johnson; G Haffenden; L Fry; E J Holborow
Journal:  J Invest Dermatol       Date:  1981-02       Impact factor: 8.551

9.  New immunofluorescent blood test for gluten sensitivity.

Authors:  D J Unsworth; P D Manuel; J A Walker-Smith; C A Campbell; G D Johnson; E J Holborow
Journal:  Arch Dis Child       Date:  1981-11       Impact factor: 3.791

10.  Wheat protein antibodies in dermatitis herpetiformis.

Authors:  J C Huff; W L Weston; D K Zirker
Journal:  J Invest Dermatol       Date:  1979-12       Impact factor: 8.551

View more
  22 in total

1.  Do adults with high gliadin antibody concentrations have subclinical gluten intolerance?

Authors:  J A Arnason; H Gudjónsson; J Freysdóttir; I Jónsdóttir; H Valdimarsson
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  IgA antiendomysial antibody test. A step forward in celiac disease screening.

Authors:  U Volta; N Molinaro; M Fusconi; F Cassani; F B Bianchi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

4.  Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy?

Authors:  C Sategna-Guidetti; G Ferfoglia; M Bruno; R Pulitano; D Roccatello; A Amore; R Coppo
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

5.  Antigliadin antibody levels in symptomless celiac disease.

Authors:  M Frisoni; U Volta; R A Valentini; E A Treggiari; G R Corazza; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

6.  IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease.

Authors:  U Volta; N Molinaro; D Fratangelo; F B Bianchi
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study.

Authors:  A Bürgin-Wolff; R Berger; H Gaze; H Huber; M J Lentze; D Nusslé
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

8.  Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis.

Authors:  U Volta; L De Franceschi; N Molinaro; F Cassani; L Muratori; M Lenzi; F B Bianchi; A J Czaja
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

9.  IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys.

Authors:  U Volta; N Molinaro; L de Franceschi; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

10.  IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy.

Authors:  U Volta; N Molinaro; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.